NCT05773053 - A Study of NT 201 Doses in the Treatment of Platysma Prominence | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

October 19, 2023

Study Completion Date

January 24, 2024

Conditions

Platysma Prominence

Interventions

DRUG

NT 201

Clostridium botulinum neurotoxin type A (150 kiloDalton \[kD\], free of complexing proteins) powder for solution for injection.

DRUG

NT 201 Placebo

NT 201 Matching-placebo.

Trial Locations (7)

Merz Investigation Site #0010469, New York

Merz Investigation Site #0010405, New York

Merz Investigation Site #0010170, Washington D.C.

Merz Investigation Site #0010470, Coral Gables

Merz Investigational Site #0010453, Aventura

Merz Investigation Site #0010105, Metairie

Merz Investigation Site #0010471, Verona